Investigating the potential of oncolytic viruses for cancer treatment via MSC delivery
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Investigating the potential of oncolytic viruses for cancer treatment via MSC delivery ; volume:21 ; number:1 ; day:4 ; month:9 ; year:2023 ; pages:1-11 ; date:12.2023
Cell communication and signaling ; 21, Heft 1 (4.9.2023), 1-11, 12.2023
- Urheber
-
Ghaleh, Hadi Esmaeili Gouvarchin
Vakilzadeh, Gazal
Zahiri, Ali
Farzanehpour, Mahdieh
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12964-023-01232-y
- URN
-
urn:nbn:de:101:1-2023111411372761815986
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ghaleh, Hadi Esmaeili Gouvarchin
- Vakilzadeh, Gazal
- Zahiri, Ali
- Farzanehpour, Mahdieh
- SpringerLink (Online service)
Ähnliche Objekte (12)
Oncolytic viruses for cancer immunotherapy
Perspectives on immunotherapy via oncolytic viruses
Oncolytic viruses as therapeutic cancer vaccines
Oncolytic Viruses: Priming Time for Cancer Immunotherapy
Engineering targeted and cytokine-armed oncolytic measles viruses
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Oncolytic viruses for triple negative breast cancer and beyond
Development of oncolytic viruses as improved therapeutics for hepatocellular carcinoma
Oncolytic viruses and checkpoint inhibitors: combination therapy in clinical trials
Versatility of DARPin-targeted oncolytic measles viruses : safety, efficacy, and specificity
Improving the therapeutic efficacy of oncolytic viruses for cancer: targeting macrophages
Oncolytic viruses for cancer immunotherapy
Perspectives on immunotherapy via oncolytic viruses
Oncolytic viruses as therapeutic cancer vaccines
Oncolytic Viruses: Priming Time for Cancer Immunotherapy
Engineering targeted and cytokine-armed oncolytic measles viruses
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Oncolytic viruses for triple negative breast cancer and beyond
Development of oncolytic viruses as improved therapeutics for hepatocellular carcinoma
Oncolytic viruses and checkpoint inhibitors: combination therapy in clinical trials
Versatility of DARPin-targeted oncolytic measles viruses : safety, efficacy, and specificity
Improving the therapeutic efficacy of oncolytic viruses for cancer: targeting macrophages
Oncolytic viruses for cancer immunotherapy
Perspectives on immunotherapy via oncolytic viruses
Oncolytic viruses as therapeutic cancer vaccines
Oncolytic Viruses: Priming Time for Cancer Immunotherapy
Engineering targeted and cytokine-armed oncolytic measles viruses
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Oncolytic viruses for triple negative breast cancer and beyond
Development of oncolytic viruses as improved therapeutics for hepatocellular carcinoma
Oncolytic viruses and checkpoint inhibitors: combination therapy in clinical trials
Versatility of DARPin-targeted oncolytic measles viruses : safety, efficacy, and specificity